切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Ca2 -ATPases - Liver X receptors (LXRs) - Gap Junctions - 5-HT7 Receptors

12件产品中的 1-10

页面
每页
清除全部
  1. Gap 27
    A1045 Gap 27
     4 Citation
    Target: Gap Junctions
    Summary: 缝隙连接阻断剂
      ≥65.25 mg/mL
      ≥5 mg/mL
  2. Gap 26
    A1044 Gap 26
     8 Citation
    Target: Gap Junctions
    Summary: 间隙连接阻断肽,对应于connexin 43的63-75 aa。
      ≥77.55 mg/mL
      ≥155.1 mg/mL
  3. SR-9243
    A8714 SR-9243
    Target: Liver X receptors (LXRs)
    Summary: LXR反相激动剂
      ≥25.2 mg/mL
      insoluble in H2O
  4. Thapsigargin
    B6614 Thapsigargin
     1 Citation
    中文名: 毒胡萝卜素
    Target: Ca2 -ATPases
    Summary: 肌质网状Ca2+-ATP酶抑制剂
      ≥39.2 mg/mL
      ≥4.12 mg/mL
  5. Lurasidone HCl
    B1477 Lurasidone HCl
    中文名: 盐酸鲁拉西酮
    Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺D2/5-HT2A/5-HT7/5-HT1A抑制剂
      ≥11.11 mg/mL
      insoluble in H2O
  6. Quetiapine Fumarate
    B1490 Quetiapine Fumarate
     1 Citation
    中文名: 富马酸奎硫平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺受体拮抗剂
      ≥11.03 mg/mL
      insoluble in H2O
  7. LXR-623
    B1264 LXR-623
     2 Citation
    Target: Liver X receptors (LXRs)
    Summary: 肝X受体激动剂
      ≥19.4 mg/mL
      insoluble in H2O
  8. Carbenoxolone disodium
    A8389 Carbenoxolone disodium
     1 Citation
    Target: Gap Junctions
    Summary: 11β-HSD抑制剂
      ≥30.74 mg/mL
      ≥55.1 mg/mL
  9. T0901317
    A2249 T0901317
    Target: Liver X receptors (LXRs)
    Summary: 肝X受体激动剂
      ≥24.05 mg/mL
      insoluble in H2O
  10. Vortioxetine
    A3926 Vortioxetine
    中文名: 沃替西汀
    Target: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERT
    Summary: 5-HT受体拮抗剂
      ≥14.92 mg/mL
      insoluble in H2O

12件产品中的 1-10

页面
每页